PATENT CLAIM ANALYSIS

Application Number: 16109127
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "020500"]

Abstract:
The invention provides pharmaceutical compositions comprising about 0.05 to 0.1% (w/v) cyclosporine dissolved in 1-perfluorobutyl-pentane for use in the topical treatment of dry eye disease and provides for dosing and treatment methods thereof. The invention further provides kits comprising such compositions.

Claim (Index 30):
A method of reducing ocular surface damage associated with dry eye disease, the method comprising topically administering twice daily to an eye of a human with dry eye disease a composition comprising about 0.1% (w/v) cyclosporine dissolved in 1-perfluorobutyl-pentane, wherein said composition is substantially free of water and is substantially free of a preservative, wherein the amount of cyclosporine administered in a single dose per eye is about 10 \u03bcg cyclosporine.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 96.0
- Lexical Diversity: 1.31429
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15142709', '15676968', '12685510', '13601258', '15742867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7472234898111991
- 35 USC 102 Novelty (BERT): 0.5139856727791172
- Combined Prediction Score: 0.723899708107991
- Mean Citation Score: 251.82278
- Max Citation Score: 280.8045
- Similarity Product: 182.7725376884937

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test